MGB-BP-3

DB12892InvestigationalSmall molecule

Mgb Bp 3 is under investigation in clinical trial NCT02518607 (Safety, Blood Levels and Effects of MGB-BP-3).

Mechanism: Pharmacologically active on DNA topoisomerase 4 subunit A, DNA gyrase subunit B, and DNA gyrase subunit A
Curator reviewed
Formula / weight: C₃₆H₃₇N₇O₄ · 631.737 g/mol (avg)
Code names: J2.725.402K

Resolves to

Compound

Structure

InChIKeyOEKXCVYZBVOWBR-BQYQJAHWSA-NSMILESCN1C=C(NC(=O)C2=CC(NC(=O)C3=CC=C(\C=C\C4=CN=C5C=CC=CC5=C4)C=C3)=CN2C)C=C1C(=O)NCCN1CCOCC1

Targets

What you can answer from here — as of October 22, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with MGB-BP-3, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.